UK Markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
71.38-0.35 (-0.49%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 589.52B
Enterprise value 3113.31B
Trailing P/E 297.42
Forward P/E 110.61
PEG ratio (5-yr expected) 17.81
Price/sales (ttm)3.36
Price/book (mrq)4.72
Enterprise value/revenue 34.25
Enterprise value/EBITDA 77.95

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 373.34
52-week low 356.56
50-day moving average 371.35
200-day moving average 367.94

Share statistics

Avg vol (3-month) 36.19M
Avg vol (10-day) 37.32M
Shares outstanding 51.25B
Implied shares outstanding 6N/A
Float 81.25B
% held by insiders 10.10%
% held by institutions 181.56%
Shares short (30 Aug 2021) 422.45M
Short ratio (30 Aug 2021) 43.74
Short % of float (30 Aug 2021) 41.79%
Short % of shares outstanding (30 Aug 2021) 41.79%
Shares short (prior month 29 Jul 2021) 425.73M

Dividends & splits

Forward annual dividend rate 42.84
Forward annual dividend yield 43.96%
Trailing annual dividend rate 32.75
Trailing annual dividend yield 33.83%
5-year average dividend yield 43.36
Payout ratio 467.80%
Dividend date 328 Sept 2021
Ex-dividend date 413 Sept 2021
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 19.38%
Operating margin (ttm)46.82%

Management effectiveness

Return on assets (ttm)12.58%
Return on equity (ttm)27.14%

Income statement

Revenue (ttm)26.64B
Revenue per share (ttm)21.21
Quarterly revenue growth (yoy)20.90%
Gross profit (ttm)21B
EBITDA 14.25B
Net income avi to common (ttm)5.16B
Diluted EPS (ttm)0.24
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.84B
Total cash per share (mrq)5.46
Total debt (mrq)30.18B
Total debt/equity (mrq)153.10
Current ratio (mrq)1.36
Book value per share (mrq)15.11

Cash flow statement

Operating cash flow (ttm)9.09B
Levered free cash flow (ttm)7.97B